NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs

Stem Cell Reports. 2017 Sep 12;9(3):853-867. doi: 10.1016/j.stemcr.2017.07.020. Epub 2017 Aug 31.

Abstract

HLA haplotype-homozygous (HLA-homo) induced pluripotent stem cells (iPSCs) are being prepared to be used for allogeneic transplantation of regenerated tissue into recipients carrying an identical haplotype in one of the alleles (HLA-hetero). However, it remains unaddressed whether natural killer (NK) cells respond to these regenerated cells. HLA-C allotypes, known to serve as major ligands for inhibitory receptors of NK cells, can be classified into group 1 (C1) and group 2 (C2), based on their binding specificities. We found that the T cells and vascular endothelial cells regenerated from HLA-homo-C1/C1 iPSCs were killed by specific NK cell subsets from a putative HLA-hetero-C1/C2 recipient. Such cytotoxicity was canceled when target cells were regenerated from iPSCs transduced with the C2 gene identical to the recipient. These results clarify that NK cells can kill regenerated cells by sensing the lack of HLA-C expression and further provide the basis for an approach to prevent such NK cell-mediated rejection responses.

Keywords: HLA haplotype-homozygote; HLA-C; KIR; KIR ligand; NK cells; iPSCs; missing-self recognition; regeneration; transplantation; vascular endothelial cells.

MeSH terms

  • Asian People
  • Cytotoxicity, Immunologic
  • HLA Antigens / metabolism*
  • Haplotypes / genetics*
  • Homozygote
  • Humans
  • Immune Tolerance
  • Induced Pluripotent Stem Cells / metabolism*
  • Killer Cells, Natural / metabolism*
  • Ligands
  • Lymphocyte Subsets / metabolism
  • Receptors, KIR / metabolism*
  • Regeneration
  • T-Lymphocytes / metabolism
  • Tissue Donors
  • Transplantation, Homologous

Substances

  • HLA Antigens
  • Ligands
  • Receptors, KIR